ArticleInternational journal of Alzheimer's disease2011

Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment.

Ana Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.